10% Chinese Peony Paeonia Lactiflora Paeoniflorin Bishushi Tablet

• Customization: Available
• Certification: ISO, Halal
• Assay Method: HPLC-MS, HPLC
• Model NO.: NY044
• Application Form: Tablet, Capsule, Softgels, Tinctures, Liquids, Drops
• Application: Health Care Products, Medicine
• State: Powder
• Extract Source: White Peony Root
• Color: Brown Yellow Powder
• Transport Package: 25kg/Drum
• Specification: 10%
• Trademark: Nutrayours/ OEM
• Origin: China
• HS Code: 1302199099
• Production Capacity: 3000kg/Year

Product Description

Paeoniflorin is extracted from the root of Paeonia albiflora Pall. It has broad pharmacological effects, such as analgesic, anti-diuretic, anti-inflammator, anti-convulsant, vasodilatic and etc. Peony Contains a unique glycoside called paeoniflorin, proanthocyanidins, flavonoids, tannins, polysaccharides and Paeoniflorin are all considered to contribute to the medicina activity of various forms of peony. Paeoniflorin and peony extracts enhance mental function in animal studies, suggesting a potential benefit for dementia. ...

 

About this item

 

• 100% NATURAL PRODUCT: No artificial colors or flavors
• Verified herb identity, confirmed highest quality of raw herb and the extract
• Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
• Third-party lab tested, pure Paeoniflorin

 

Product Name:	Paeoniflorin
CAS:	23180-57-6
MF:	C23H28O11
MW:	480.47
EINECS:	245-476-2
Product Categories:	A reference substance; Natural products; Traditional Chinese medicine reference; Analytical standard; Plant extract; Plant biochemical extract; Pharmaceutical raw materials; Small molecule inhibitor; Natural products; Standard extract; Other biochemical reagents; Chinese herbal ingredients; Heterocycles; Peoniflorin series; Traditional Chinese medicine standard; Extract; Bulk drug; Traditional Chinese medicine, phytochemical drugs; High purity plant extract; Phytomonomer; Fragrance and fragrance; Raw materials; Other terpenoids; Analytical reagents - standard; Pharmaceutical ingredients
Molecular Structure:

 

About us

* The statements in this section have not been evaluated by the FDA or EFSA.

References




1.Zhang L, Wei W.Pharmacol Ther. 2020 Mar;207:107452. doi: 10.1016/j.pharmthera.2019.107452. Epub 2019 Dec 10.PMID: 31836457
2.Ma Y, Lang X, Yang Q, Han Y, Kang X, Long R, Du J, Zhao M, Liu L, Li P, Liu J.Int Immunopharmacol. 2023 Jun;119:110247. doi: 10.1016/j.intimp.2023.110247. Epub 2023 May 7.PMID: 37159966
3.Wang Y, You K, You Y, Li Q, Feng G, Ni J, Cao X, Zhang X, Wang Y, Bao W, Wang X, Chen T, Li H, Huang Y, Lyu J, Yu S, Li H, Xu S, Zeng K, Shen X.Pharmacol Res. 2022 Aug;182:106309. doi: 10.1016/j.phrs.2022.106309. Epub 2022 Jun 16.PMID: 35716915
4.Wang XL, Feng ST, Wang YT, Chen NH, Wang ZZ, Zhang Y.Phytomedicine. 2021 Sep;90:153669. doi: 10.1016/j.phymed.2021.153669. Epub 2021 Jul 22.PMID: 34334273 
5Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.Acta Pharmacol Sin. 2016 Jun;37(6):794-804. doi: 10.1038/aps.2016.36. Epub 2016 May 2.PMID: 27133302 
6.Ren S, Wang Y, Zhang Y, Yan P, Xiao D, Zhao Y, Jia W, Ding L, Dong H, Wei C, Lin S, Lin Y.Biomed Pharmacother. 2023 Sep;165:115253. doi: 10.1016/j.biopha.2023.115253. Epub 2023 Aug 3.PMID: 37542855